在两个已建立的筛查方案中，一种附加的、基于血液的结直肠癌筛查试验的诊断准确性

IF 6.6 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Alimentary Pharmacology & Therapeutics Pub Date : 2025-04-10 DOI:10.1111/apt.70141

Tim L. Kortlever, Enea Ferlizza, Mattia Lauriola, Francesco Borrelli, Alberto Porro, Manon C. W. Spaander, Patrick M. Bossuyt, Luigi Ricciardiello, Evelien Dekker

{"title":"在两个已建立的筛查方案中，一种附加的、基于血液的结直肠癌筛查试验的诊断准确性","authors":"Tim L. Kortlever, Enea Ferlizza, Mattia Lauriola, Francesco Borrelli, Alberto Porro, Manon C. W. Spaander, Patrick M. Bossuyt, Luigi Ricciardiello, Evelien Dekker","doi":"10.1111/apt.70141","DOIUrl":null,"url":null,"abstract":"CELTiC is a blood-based test consisting of a panel of four mRNAs (CEACAM6, LGALS4, TSPAN8 and COL1A2) associated with colorectal cancer (CRC). CELTiC has a high sensitivity (90%) for detecting advanced neoplasia (AN) when compared to faecal immunochemical test (FIT)-negative subjects.","PeriodicalId":121,"journal":{"name":"Alimentary Pharmacology & Therapeutics","volume":"78 1","pages":""},"PeriodicalIF":6.6000,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diagnostic Accuracy of an Add-On, Blood-Based Screening Test for Colorectal Cancer in Two Established Screening Programmes\",\"authors\":\"Tim L. Kortlever, Enea Ferlizza, Mattia Lauriola, Francesco Borrelli, Alberto Porro, Manon C. W. Spaander, Patrick M. Bossuyt, Luigi Ricciardiello, Evelien Dekker\",\"doi\":\"10.1111/apt.70141\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"CELTiC is a blood-based test consisting of a panel of four mRNAs (CEACAM6, LGALS4, TSPAN8 and COL1A2) associated with colorectal cancer (CRC). CELTiC has a high sensitivity (90%) for detecting advanced neoplasia (AN) when compared to faecal immunochemical test (FIT)-negative subjects.\",\"PeriodicalId\":121,\"journal\":{\"name\":\"Alimentary Pharmacology & Therapeutics\",\"volume\":\"78 1\",\"pages\":\"\"},\"PeriodicalIF\":6.6000,\"publicationDate\":\"2025-04-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alimentary Pharmacology & Therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/apt.70141\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/apt.70141","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

CELTiC是一种基于血液的检测，包括与结直肠癌（CRC）相关的四种mrna （CEACAM6、LGALS4、TSPAN8和COL1A2）。与粪便免疫化学试验（FIT）阴性受试者相比，CELTiC在检测晚期肿瘤（AN）方面具有很高的灵敏度（90%）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Diagnostic Accuracy of an Add-On, Blood-Based Screening Test for Colorectal Cancer in Two Established Screening Programmes

查看原文本刊更多论文

Diagnostic Accuracy of an Add-On, Blood-Based Screening Test for Colorectal Cancer in Two Established Screening Programmes

CELTiC is a blood-based test consisting of a panel of four mRNAs (CEACAM6, LGALS4, TSPAN8 and COL1A2) associated with colorectal cancer (CRC). CELTiC has a high sensitivity (90%) for detecting advanced neoplasia (AN) when compared to faecal immunochemical test (FIT)-negative subjects.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Alimentary Pharmacology & Therapeutics 医学-胃肠肝病学

CiteScore

15.60

自引率

7.90%

发文量

527

审稿时长

3-6 weeks

期刊介绍： Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.